Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
solanezumab
Podcast
'The Top Line': The SVB failure, plus this week's headlines
This week on "The Top Line," we discuss the SVB failure, what to expect next and what it all meant for biotech, plus this week's top headlines.
Teresa Carey
Mar 17, 2023 6:00am
Pipeline concerns cast pall on Lilly's Q1 beat
Apr 25, 2017 10:38am
Retired Lilly chief Lechleiter hauls in $18.4M in executive pay
Mar 24, 2017 9:14am
Eli Lilly slashes 485 jobs, largely in faltering Alzheimer’s unit
Jan 20, 2017 9:37am
Lilly to lay off sales reps in wake of Alzheimer's failure
Dec 7, 2016 11:45am
